Zhuhai Qianlie Pharmaceutical Co., Ltd. announced that it has raised not more than CNY 25 million in an equity round of funding on October 16, 2023. The transaction involved participation from new investor Hunan Warrant Pharmaceutical Co.,Ltd. invest no more than CNY 22 million and Zhuhai Qianlie Pharmaceutical Co., Ltd. for invest no more than CNY 3 million. This transaction has been reviewed and approved at the sixth extraordinary meeting of the company's third board of directors and the sixth extraordinary meeting of the third board of supervisors of Hunan Warrant Pharmaceutical Co.,Ltd.